Financials
- Market Capitalization 892.87 M
- Employee 19
- Founded 2007
- CEO William H. Collier
- Website www.arbutusbio.com
- Headquarter British Columbia, Canada
- FIGI BBG000RR8V85
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2533 | DBVT DBV Technologies S.A. - American Depositary Shares | 15.62 USD | -1.88% | -4.76% | -14.69% | +61.36% | 924.84 M USD | ||
| 2541 | LBRX LB Pharmaceuticals Inc - Common Stock | 31.76 USD | -0.81% | -6.75% | +10.51% | +67.16% | 910.77 M USD | ||
| 2555 | GERN Geron Corporation - Common Stock | 1.41 USD | +2.17% | -4.73% | +22.61% | +10.16% | 904.54 M USD | ||
| 2567 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.94 USD | +0.12% | -0.35% | +3.17% | +18.05% | 873.31 M USD |
Frequently asked questions about Arbutus Biopharma Corporation - Common Stock
What is the Arbutus Biopharma Corporation - Common Stock stock price today?
The current price of Arbutus Biopharma Corporation - Common Stock (ABUS) is 4.52. Over the past 24 hours, the stock has changed by -1.95%. Follow the ABUS chart for real-time price dynamics.
What is the stock ticker of Arbutus Biopharma Corporation - Common Stock?
Arbutus Biopharma Corporation - Common Stock trades under the ticker ABUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arbutus Biopharma Corporation - Common Stock stock going up?
ABUS has changed by -10.50% over the last week, +3.91% over the last month, and +44.41% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arbutus Biopharma Corporation - Common Stock net income for the last quarter?
Arbutus Biopharma Corporation - Common Stock reported net income of 169.69 M for the last quarter. The previous quarter showed -3.76 M, which means net income changed by +4617.97%.
How many employees does Arbutus Biopharma Corporation - Common Stock have?
As of the latest available data, Arbutus Biopharma Corporation - Common Stock has 19 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arbutus Biopharma Corporation - Common Stock EBITDA?
Arbutus Biopharma Corporation - Common Stock EBITDA is 168.92 M, and its EBITDA margin is 94.3%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arbutus Biopharma Corporation - Common Stock stock?
You can buy Arbutus Biopharma Corporation - Common Stock (ABUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arbutus Biopharma Corporation - Common Stock stock?
Investing in Arbutus Biopharma Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABUS chart and related analysis on metatrader.com as part of your research.